|
2018 Journal Article Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03Poulsen, Michael, Macfarlane, David, Veness, Michael, Estall, Venessa, Hruby, George, Kumar, Mahesh, Pullar, Andrew, Tripcony, Lee and Rischin, Danny (2018). Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03. Journal of Medical Imaging and Radiation Oncology, 62 (3), 412-419. doi: 10.1111/1754-9485.12705 |
|
2018 Conference Publication A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabineVan der Zwan, W., Wyld, D., Brabander, T., Teunissen, J., Kam, B., MacFarlane, D., Krenning, E., Kwekkeboom, D. and de Herder, W. (2018). A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7 - 9 March 2018. Basel, Switzerland: S. Karger AG. |
|
2015 Journal Article Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100BWinter, Craig, Bell, Christopher, Whyte, Timothy, Cardinal, John, Macfarlane, David and Rose, Stephen (2015). Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100B. Neurological Research, 37 (7), 599-606. doi: 10.1179/1743132815Y.0000000018 |
|
2015 Journal Article A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancersBurge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418 |
|
2014 Conference Publication Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATELee, K., Conway, L., Burge, M., Wyld, D. and Macfarlane, D. (2014). Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2014 Conference Publication Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyraponeChan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2013 Journal Article The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PETLaw, W.P., Fiumara, F., Fong, W. and MacFarlane, D.J. (2013). The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PET. Journal of Medical Imaging and Radiation Oncology, 57 (6), 680-683. doi: 10.1111/1754-9485.12069 |
|
2013 Conference Publication Breath-hold low dose CT immediately following PET/CT enables good quality virtual bronchoscopy prior to EBUS guide sheath biopsyFielding, David, Bashirzadeh, Farzad, Smith, Jye, Garcia, Peter, Frecker, Sue and Macfarlane, David (2013). Breath-hold low dose CT immediately following PET/CT enables good quality virtual bronchoscopy prior to EBUS guide sheath biopsy. New York, NY, United States: Elsevier. |
|
2012 Conference Publication Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's HospitalSharma, A., Burge, M., MacFarlane, D., McDade, H., Kemp, S. and Wyld, D. (2012). Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's Hospital. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting , Brisbane, QLD, Australia, 8 – 10 August 2012. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2011 Journal Article Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView)Morris, Timothy A., Gerometta, Michael, Yusen, Roger D., White, Richard H., Douketis, James D., Kaatz, Scott, Smart, Richard C., Macfarlane, David and Ginsberg, Jeffrey S. (2011). Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView). American Journal of Respiratory and Critical Care Medicine, 184 (6), 708-714. doi: 10.1164/rccm.201104-0624OC |
|
2011 Journal Article Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECTMorris, Timothy A., Gerometta, Michael, Smart, Richard C., Eisenberg, Paul, Roach, Paul J., Tsui, Wendy W., Better, Nathan, Taubman, Kim L., Unger, Steven A. and Macfarlane, David (2011). Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECT. Heart, Lung and Circulation, 20 (8), 503-511. doi: 10.1016/j.hlc.2011.03.113 |
|
2011 Journal Article Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinibMileshkin, Linda, Hicks, Rodney J., Hughes, Brett G. M., Mitchell, Paul L. R., Charu, Veena, Gitlitz, Barbara J., Macfarlane, David, Solomon, Benjamin, Amler, Lukas C., Yu, Wei, Pirzkall, Andrea and Fine, Bernard M. (2011). Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clinical Cancer Research, 17 (10), 3304-3315. doi: 10.1158/1078-0432.CCR-10-2763 |
|
2011 Journal Article Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancerBinns, David S., Pirzkall, Andrea, Yu, Wei, Callahan, Jason, Mileshkin, Linda, Conti, Peter, Scott, Andrew M., Macfarlane, David, Fine, Bernard M., Hicks, Rodney J. and OSI3926g Study Team (2011). Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging, 38 (4), 642-650. doi: 10.1007/s00259-010-1665-0 |
|
2011 Conference Publication Radiopeptide lite - an automated radiopeptide labelling system using disposable cassettesCombs, M., Stimson, D., Yordanov, A. and Macfarlane, D. (2011). Radiopeptide lite - an automated radiopeptide labelling system using disposable cassettes. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Darwin, NT, Australia, 14 ‐ 18 July 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2011 Conference Publication Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective studyBurge, M., Houston, K. E., Francesconi, A., O'Rourke, N., Lee, J., Macfarlane, D., Wyld, D., Hopkins, G., Finch, R. and Nathanson, L. (2011). Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective study. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011. Elsevier: Oxford, United Kingdom. |
|
2011 Conference Publication (68)Ga-dotatate: synthesis, automation, and quality controlStimson, D., Macfarlane, D., Combs, M. and Yordanov, A. (2011). (68)Ga-dotatate: synthesis, automation, and quality control. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Darwin, NT, Australia, 14 ‐ 18 July 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2010 Conference Publication Improved delineation of brain tumour margins using whole-brain track-density mappingRose, S., Crozier, S., Bourgeat, P., Dowson, N., Salvado, O., Raniga, P., Pannek, K., Coulthard, A., Fay, M., Thomas, P. and MacFarlane, D. (2010). Improved delineation of brain tumour margins using whole-brain track-density mapping. ISMRM-ESMRMB Joint Annual Meeting 2010: Clinical Needs and Technological Solutions, Stockholm, Sweden, 1-7 May 2010. New York, USA: International Society of Magnetic Resonance in Medicine. |
|
2010 Conference Publication Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patientsDowson, N., Bourgeat, P., Rose, S., Daglish, M., Smith, J., Fay, M., Coulthard A., Winter, C., MacFarlane, D., Thomas, P., Crozier, S. and Salvado, O. (2010). Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients. 13th International Conference on Medical Image Computing and Computer-Assisted Intervention, MICCAI 2010, Beijing, China, 20 - 24 September 2010. Heidelberg, Germany: Springer. doi: 10.1007/978-3-642-15745-5_23 |
|
2009 Journal Article Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancersHerbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536 |
|
2009 Journal Article Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosisFrancesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6 |
